US Patent 11771741 Nucleic acid construct that encodes chimeric rhodopsin
Patent 11771741 was granted and assigned to Restore Vision Inc. on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 28, 2022
Date of Patent
October 3, 2023
Patent Applicant
Patent Application Number
17731976
Patent Inventor Names
Toshihide Kurihara
Hideki Kandori
Kazuo Tsubota
Yusaku Katada
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11771741 Nucleic acid construct that encodes chimeric rhodopsin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
